Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative.
European Journal of Cancer.
Times cited: 60
Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma.
Journal for ImmunoTherapy of Cancer.
Times cited: 25
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.
Clinical Cancer Research.
Times cited: 51
Ewing's sarcoma and primitive neuroectodermal family of tumors.
Hematology/Oncology Clinics of North America.
Times cited: 102